MRNA Quick Ratio Analysis
Updated 5h ago·SEC filings & market data
Key Takeaway
The quick ratio measures whether a company can cover its short-term obligations using only its most liquid assets, and 0.69x means MRNA has $0.69 in cash and near-cash assets for every $1 of short-term liabilities.
Sector Performance
47th percentileMRNA
0.69x
Sector Median
0.72x
Sector Avg
2.70x
Prior Period
0.83x(Aug 2026)
Deep Analysis
The quick ratio measures whether a company can cover its short-term obligations using only its most liquid assets, and 0.69x means MRNA has $0.69 in cash and near-cash assets for every $1 of short-term liabilities.
This is below the sector median of 0.72x, placing MRNA at the 48th percentile among sector peers, so liquidity is broadly in line with the middle of the pack. The 8-quarter trend direction is not available, and the year-over-year change is also not available, but quarter-over-quarter the ratio moved from 0.83x to 0.69x, a decline of -16.9%. That drop, combined with a ratio already under 1.0x, points to shrinking liquidity cushion and could raise near-term financing or cash-flow concerns. For an investor, this level is a caution flag rather than an opportunity, since the ability to meet obligations without selling other assets is weakening. This metric supports the overall CAUTIOUS verdict directly, as the latest quick ratio is below the sector benchmark and falling sharply on a quarterly basis.
Frequently Asked Questions
What does the Quick Ratio tell investors about MRNA?
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
How is the Quick Ratio calculated?
Quick Ratio is calculated as: (Cash + Receivables) / Current Liabilities.
Who are MRNA's closest peers by Quick Ratio?
The closest peers by Quick Ratio include: OMC (0.67x), KO (0.66x), SIEGY (0.64x), TAP (0.60x), LW (0.60x).
Learn More About Quick Ratio
The Formula
(Cash + Receivables) / Current Liabilities
Why It Matters
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
Master MRNA's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MRNA research report →MRNA
0.69x
Sector Median
0.72x
Sector Avg
2.70x
How MRNA's Quick Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.